Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at Goldman Sachs Global Healthcare Conference Transcript

Jun 14, 2022 / NTS GMT
Release Date Price: $49 (-2.35%)
Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Good evening, good morning, good afternoon, everyone, and thank you for joining us. My name is Keyur Parekh, and I cover Sanofi for Goldman Sachs. Dietmar, thank you so much for taking the time to join us in California. Unfortunately, I'm stuck in somewhat sunny London. So that's kind of the saving grace, but thank you again for making the trip. I appreciate it.

Dietmar, before we kind of go to Q&A, just (inaudible) of introduction for everybody listening in. Dietmar is the head of Global kind of Development and the Chief Medical Officer for Sanofi, having joined Sanofi about 2.5 years back.

Dietmar, I don't know if you want to make some opening comments on kind of your 2.5 years at Sanofi, how that's kind of progressed, the kind of changes you've made, what you see -- what excites you today before we get into specific stuff.

Dietmar P. Berger
Sanofi - Chief Medical Officer & Global Head of Development

Yes, Great. Thanks for having me, first of all, and this is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot